ArticleCell biochemistry and biophysics2026
Synthesis of Apolipoprotein A-I in Human Macrophages Enhances their Migratory Activity.
Article in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Apolipoprotein A-I (ApoA-I) is the major structural and functional protein of high density lipoprotein (HDL) particles. ApoA-I has antioxidant, anti-inflammatory and atheroprotective properties. Although the main sites of ApoA-I synthesis in humans are liver and small intestine, ApoA-I expression was also found in monocytes and macrophages. In the present study we demonstrate the involvement of ApoA-I, synthesized by macrophages, in the regulation of migratory activity of these cells induced by C5a. ApoA-I in macrophages enhances migration of these cells via ABCA1-independent mechanism. Exogenous and endogenous (synthesized by macrophages) ApoA-I have the different effects on the macrophage migration, activating the different targets. We have revealed the mechanism of ApoA-I-dependent stimulation of macrophage chemotaxis: endogenous ApoA-I decreases the synthesis and secretion of netrin-1 (an inhibitor of macrophage emigration from the atherosclerotic plaque into the lymph nodes) and also downregulates its receptor UNC5B. Moreover, the incubation of macrophages with netrin-1 reduced mRNA and membrane-associated levels of ApoA-I, that proved the existence of negative feedback loop between netrin-1 and ApoA-I in macrophages.
Indexed as
Identifiers
41854983What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.